| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in SNSE over the last quarter tilts toward selling: insiders offloaded a net 34,359 shares worth roughly $600K.
Classified under Biotechnology (Health Care sector), SNSE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 1.24M | - | - | |
| Pres | 220.0K | - | - | |
| 10% | 130.6K | $2.61M | - | |
| 10% | 130.6K | $2.61M | - | |
| Other | 80.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 5,000 | $16.25 | $81,250.00 | +0.1% | |
| Feb 25, 2021 | Peyer James | Director, 10% Owner | Buy | 31,000 | $16.48 | $510,862.00 | +0.2% | |
| Feb 25, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 31,000 | $16.48 | $510,862.00 | +0.2% | |
| Feb 23, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 20,300 | $17.79 | $361,070.00 | +0.2% | |
| Feb 23, 2021 | Peyer James | Director, 10% Owner | Buy | 20,300 | $17.79 | $361,070.00 | +0.2% | |
| Feb 22, 2021 | Peyer James | Director, 10% Owner | Buy | 9,802 | $18.88 | $185,061.76 | +0.2% | |
| Feb 22, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 9,802 | $18.88 | $185,061.76 | +0.2% | |
| Feb 19, 2021 | Peyer James | Director, 10% Owner | Buy | 11,786 | $19.77 | $233,009.22 | +0.3% | |
| Feb 19, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 11,786 | $19.77 | $233,009.22 | +0.3% | |
| Feb 18, 2021 | Peyer James | Director, 10% Owner | Buy | 753 | $19.75 | $14,871.75 | - |